drugset / Trial / NCT00607295

Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients

NCT00607295 ↗

Phase 3 Completed 98 enrolled Seoul National University Hospital
RandomizedParallel-groupSingle-blindSupportive care

Summary

1. Although after treatment for breast cancer such as chemotherapy or hormonal therapy, urogenital atrophy is common, the patients are seldomly treated for several reasons. Management of this problem is important for improving quality of life. 2. "Clino-san" is a kind of vaginal lubricant with pH 5 which is similar pH of premenopausal vaginal discharge. After randomization of patients, they are treated with Clino-san or placebo 3 times/week for 12 weeks. 3. We check the vaginal symptoms, vag dryness severity score, and ultrasonography at baseline, 4, 8, and 12 weeks of treatment.

Timeline

Start
2007-12
Primary completion
2008-12
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Clino-san Unknown 2 ml Topical